Intracranial Aneurysm Market - By Treatment Type (Endovascular Coiling, Surgical Clipping, Flow Diverters), By End-use (Hospitals, Clinics) – Global Forecast, 2023-2032

Intracranial Aneurysm Market - By Treatment Type (Endovascular Coiling, Surgical Clipping, Flow Diverters), By End-use (Hospitals, Clinics) – Global Forecast, 2023-2032

Intracranial Aneurysm Market Size

Intracranial Aneurysm Market size was valued at USD 1.2 billion in 2022 and is estimated to reach USD 2.7 billion by 2032. The global aging population is a significant driver for the market.
 

Aneurysms are more common in older individuals, and as the population ages, there is a higher prevalence of this condition. For instance, according to a recent United Nations (UN) research, the number of people aged 65 and over globally is predicted to treble over the next three decades. The senior population is expected to reach 1.6 billion by 2050, accounting for more than 16% of the worldwide population. Older patients are more likely to require diagnosis and treatment for intracranial aneurysms.
 

Moreover, technological advancement in the field of neurovascular interventions is growing. These advancements include the development of innovative neurovascular devices, imaging techniques, and minimally invasive procedures. Advanced devices and techniques have improved the accuracy of diagnosis and the effectiveness of treatment, resulting in better outcomes for patients, contributing to market progress.
 

Intracranial aneurysm is a medical condition characterized by a localized, abnormal bulging or ballooning in the wall of a blood vessel within the brain. This bulging occurs due to a weakening in the blood vessel wall, and it can cause a potentially life-threatening situation if the aneurysm ruptures.
 

COVID-19 Impact

The COVID-19 pandemic had significant impact on the intracranial aneurysm market. It has resulted in a reduction in the number of elective surgeries, such as cerebral aneurysm treatments. This is due to a combination of issues, including the diversion of healthcare resources to COVID-19 treatment, patient worries about catching the virus, and practical difficulties in performing elective surgeries during a pandemic. The COVID-19 pandemic, on the other hand, has led to an increase in the number of individuals with intracranial aneurysm rupture. This is inclined to be due to a combination of reasons, including elevated stress levels induced by the pandemic, disruptions in normal healthcare services, and delayed identification and treatment of aneurysms.
 

Intracranial Aneurysm Market Trends

The market is experiencing several notable trends that are shaping its growth and development. Some key trends include growing preference toward minimally invasive endovascular techniques for treating intracranial aneurysms, evolving regulatory standards and changes in reimbursement policies, and increasing advanced neuroimaging technologies, such as high-resolution magnetic resonance angiography (MRA) and computed tomography angiography (CTA), improved the early detection and precise diagnosis of intracranial aneurysms, enabling timely intervention.
 

• There was an increasing emphasis on personalized and patient-centered care, with treatment plans tailored to individual patient needs. This trend prioritized minimizing the impact of treatment on a patient's quality of life.
   
• Moreover, there was continued research into new treatment methods and devices, as well as participation in clinical trials to test their safety and efficacy. These efforts aimed to expand the options available to patients and improve outcomes.
   

Intracranial Aneurysm Market Analysis

The market by treatment type is categorized into endovascular coiling, surgical clipping, flow diverters, and other treatment types. The endovascular coiling segment garnered USD 854.7 million revenue size in the year 2022.
 

• Endovascular coiling is a less invasive alternative to traditional surgical clipping. This approach involves inserting a catheter through the arteries, typically via the femoral artery, and guiding it to the aneurysm site. The minimally invasive nature of coiling leads to reduced surgical trauma, shorter hospital stays, and quicker recovery times for patients.
   
• Furthermore, endovascular coiling has been associated with better patient outcomes compared to surgical clipping in certain cases. It reduces the risk of complications such as infection, brain damage, and post-operative bleeding. Patients often experience less pain and discomfort, which has fueled the growth of endovascular coiling.
   

The intracranial aneurysm market by end-use is categorized into hospitals, clinics, and other end-users. The hospitals segment garnered USD 1 billion revenue size in the year 2022.
 

• Hospitals house specialized neurosurgeons, neurointerventional radiologists, and healthcare teams experienced in the diagnosis and treatment of intracranial aneurysms. These experts are essential for delivering high-quality care and conducting complex procedures such as endovascular coiling and surgical clipping.
   
• Additionally, hospitals have access to advanced medical equipment, including angiography suites, MRI machines, CT scanners, and surgical suites equipped for intracranial aneurysm treatment. These facilities are necessary for accurate diagnosis and interventional procedures. This is anticipated to boost the segment expansion.
   

North America intracranial aneurysm market accounted for USD 433.8 million revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline.
 

• North America, including the U.S. and Canada, has a significant burden of intracranial aneurysms, partly due to lifestyle factors like smoking and hypertension. This high prevalence drives the demand for diagnosis and treatment.
   
• Furthermore, North America boasts advanced healthcare infrastructure, with access to state-of-the-art medical facilities, diagnostic technologies, and a skilled healthcare workforce. These resources are critical for the accurate diagnosis and treatment of aneurysms, contributing to the regional growth in the market.
   

Intracranial Aneurysm Market Share

The intracranial aneurysm industry is fairly consolidated in nature, with major companies competing to offer superior intracranial aneurysm in this business space. Prominent players such as Medtronic, Stryker, and Johnson & Johnson Services, Inc. hold a significant share in this market. These companies are diligently directing their efforts towards continuous treatment type innovation to gain substantial market share.

Some of the eminent market participants operating in the intracranial aneurysm industry include

• Medtronic
• Stryker
• MicroPort Scientific Corporation
• Johnson & Johnson Services, Inc.
• MicroVention Inc.
• Integra LifeSciences
• B. Braun Melsungen AG
• Delta Surgical
• Mizuho Medical Co. Ltd.
• Penumbra, Inc.

Intracranial Aneurysm Industry News

• In January 2021, MicroVention, Inc., a Terumo subsidiary and globally neurovascular firm, announced the FDA approval of the PMA supplement for the WEB 17 system, a novel addition to the WEB aneurysm embolization system for the treatment of intracranial broad neck bifurcation aneurysms. The WEB 17 System offers various combinations of devices as well as a reduced profile delivery system compatible with the VIA 17 microcatheter.
   
• In April 2021, Medtronic plc announced that it received FDA approval for its Pipeline Flex Embolization Device with Shield Technology. This device regulates blood flow away from an aneurysm in the brain, and it consists of a braided cylindrical mesh tube implanted at the base, or neck, of the aneurysm. The device stops blood flow into the aneurysm, allowing the damaged part of the parent artery to be healed.
   

Intracranial aneurysm market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Treatment Type, 2018-2032 (USD Million)

• Endovascular coiling
• Surgical clipping
• Flow diverters
• Other treatment types

By End-use, 2018-2032 (USD Million)

• Hospitals
• Clinics
• Other end-users

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Israel
  • Rest of Middle East & Africa